Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection

Clinical Infectious Diseases

Volumn 67, Issue 10, 2018, Pages 1477-1492

  Chung, Raymond T ^b   Ghany, Marc G ^b   Kim, Arthur Y ^a   Marks, Kristen M ^b   Naggie, Susanna ^b   Vargas, Hugo E ^b   Aronsohn, Andrew I ^b   Bhattacharya, Debika ^b   Broder, Tina ^b   Falade Nwulia, Oluwaseun O ^b   Fontana, Robert J ^b   Gordon, Stuart C ^b   Heller, Theo ^b   Holmberg, Scott D ^b   Jhaveri, Ravi ^b   Jonas, Maureen M ^b   Kiser, Jennifer J ^b   Linas, Benjamin P ^b   Lo Re, Vincent ^b   Morgan, Timothy R ^b   Nahass, Ronald G ^b   Peters, Marion G ^b   Reddy, K Rajender ^b   Reynolds, Andrew ^b   Scott, John D ^b   Searson, Gloria ^b   Swan, Tracy ^b   Terrault, Norah A ^b   Trooskin, Stacey B ^b   Wong, John B ^b   Workowski, Kimberly A ^b   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

chronic HCV treatment; direct acting antiviral treatment; HCV guidance; hepatitis C

Indexed keywords

ELBASVIR PLUS GRAZOPREVIR; GLECAPREVIR PLUS PIBRENTASVIR; LEDIPASVIR PLUS SOFOSBUVIR; NONSTRUCTURAL PROTEIN 5A INHIBITOR; PEGINTERFERON; PROTEINASE INHIBITOR; RIBAVIRIN; SOFOSBUVIR; SOFOSBUVIR PLUS VELPATASVIR; SOFOSBUVIR PLUS VELPATASVIR PLUS VOXILAPREVIR; VIRUS RNA; ANTIVIRUS AGENT;

ACUTE HEPATITIS C; ANTIVIRAL THERAPY; ARTICLE; CHRONIC HEPATITIS C; COMPENSATED LIVER CIRRHOSIS; DECOMPENSATED LIVER CIRRHOSIS; EVIDENCE BASED PRACTICE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HEPATITIS C VIRUS GENOTYPE 5; HEPATITIS C VIRUS GENOTYPE 6; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION DRUG USER; KIDNEY FAILURE; LIVER TRANSPLANTATION; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; NONHUMAN; PEDIATRICS; PREGNANCY; PRIORITY JOURNAL; PRISONER; RECURRENT INFECTION; RETREATMENT; CHRONIC KIDNEY FAILURE; COMPLICATION; DRUG EFFECT; HEPACIVIRUS; PRACTICE GUIDELINE; UNITED STATES;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES;

EID: 85055612827     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciy585     Document Type: Article

References (0)